Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-12

Clinical Trial Update: Efficacy of Bumetanide in Children With Autism Spectrum Disorder Guided by Peripheral Blood Biomarkers and Machine Learning Models [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating bumetanide for autism in children, using peripheral blood biomarkers and machine-learning models…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

Sponsor: Fei Li | Conditions: Autism Spectrum Disorder | Phase 2 | Status: RECRUITING